Premise Child Health COVID-19 Health Services Disruption Survey 2021
Survey:
Cross-sectional - Individual
Infectious diseases
Dataset Records for Infectious diseases
Displaying 1 - 50 of 1609
Premise Child Health COVID-19 Health Services Disruption Survey 2021
Longitudinal SARS-CoV-2 seroprevalence in Portugal and antibody maintenance 12 months after the start of the COVID-19 pandemic. Preprint
GHDx Entry last modified on: Sep 13, 2022
Brazil - Sergipe Evolution of the Prevalence of SARS-CoV-2 Infection 2021, Third Phase
Evolução da Prevalência de Infecção por SARS-CoV-2 em Sergipe. Terceira Fase: 18 de fevereiro a 30 de março de 2021.
Survey:
Epi surveillance
Netherlands - Coronavirus antibodies in an average of 18.6% of the donors
Antistoffen coronavirus bij gemiddeld 18,6% van de donors
Benin Health Statistical Yearbook 2021
Annuaire Des Statistiques Sanitaires Annee 2021
Report:
Epi surveillance - Nationally representative - Urban-rural representative
COVID-19 antibody seroprevalence in Duhok, Kurdistan Region, Iraq: A population-based study. Preprint
GHDx Entry last modified on: Mar 14, 2022
Zimbabwe COVID-19 Daily Update 2021
GHDx Entry last modified on: Dec 22, 2022
Brazil - São Paulo Household Survey to Estimate the Seroprevalence of SARS-CoV-2 Infection, Phase 5 (SoroEpi MSP)
Avaliação da prevalência da infecção pelo vírus SARS-CoV-2 em habitantes do município de São Paulo: Resultados Parciais da Fase 5
Japan Provisional Cases of Notifiable Diseases by Prefecture 2021
IDWR Surveillance Data Table 2021: Notifiable Diseases
Epi surveillance:
Subnationally representative
India COVID-19 Crowdsourced Patient Database: Vaccine Doses Administered by State
GHDx Entry last modified on: Nov 15, 2022
Japan Provisional Cumulative Cases of Diseases per Sentinel Reporting by Prefecture 2021
IDWR Surveillance Data Table 2021: Sentinel-Reporting Diseases (Weekly)
Epi surveillance:
Subnationally representative
Bhutan Royal Centre for Disease Control Quarterly Bulletin: First Quarter, Volume 25, January-March 2021
RCDC 1st Quarterly Bulletin Volume 25, Jan -March 2021
Epi surveillance:
Subnationally representative
Prevalence of SARS-CoV-2 antibodies in Denmark 2020: results from nationwide, population-based sero-epidemiological surveys. Preprint
GHDx Entry last modified on: May 12, 2022
Serum-epidemiological Survey of SARS-CoV-2, Cities of Xai-Xai and Chókwè (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Xai-Xai e Chókwè (InCOVID 2020) - Resultados Preliminares -
High Seroprevalence of SARS-CoV-2 Eight Months After Introduction in Nairobi, Kenya. Preprint
GHDx Entry last modified on: May 12, 2022
Puerto Rico Community Assessment for Response to Public Health Emergencies (CASPER) 2020
Evaluación Comunitaria para la Respuesta a Emergencias de Salud Pública (CASPER)
Survey:
Epi surveillance
Seroprevalence of antibodies against SARS-CoV-2 virus in the adult Norwegian population, winter 2020/2021: pre-vaccination period. Preprint
GHDx Entry last modified on: May 12, 2022
Nepal National Sero-Prevalence Survey for COVID-19 2020 Round 1
ENHANCED SURVEILLANCE ON SERO-PREVALENCE OF SARS-COV-2 IN GENERAL POPULATION
4.7% of the Austrian population had antibodies against SARS-CoV -2 in mid / late October
GHDx Entry last modified on: May 12, 2022
Brazil - Maranhão Prevalence of SARS-CoV-2 Virus Infection Survey 2020 Phase II
Prevalência de infecção pelo vírus SARS-CoV-2 no Maranhão, segunda fase
Survey:
Individual - Interview
Bhutan Royal Centre for Disease Control Quarterly Disease Surveillance Bulletin: Fourth Quarter, October-December 2020
RCDC Surveillance Bullletin, Volume 24, 4th Quarter 2020 (1st Quarter to 30 December) 2020
Epi surveillance:
Subnationally representative
Brazil - Sao Paulo Household Survey to Estimate the Seroprevalence of SARS-CoV-2 Infection, Phase 4 (SoroEpi MSP)
Avaliação da prevalência da infecção pelo vírus SARS-CoV-2 em habitantes do município de São Paulo: Resultados Parciais da Fase 4
Canada COVID-19 Seroprevalence in Ontario: September 3 to October 30, 2020
GHDx Entry last modified on: May 12, 2022
Serum-epidemiological Survey of SARS-CoV-2, City of Lichinga (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Lichinga (InCOVID 2020) - Resultados Preliminares -
Population-based seroprevalence of SARS-CoV-2 antibodies in a high-altitude setting in Peru. Preprint
GHDx Entry last modified on: May 12, 2022
Serum-epidemiological Survey of SARS-CoV-2, City of Beira (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Beira (InCOVID 2020) - Resultados Preliminares -
Serum-epidemiological Survey of SARS-CoV-2, City of Tete (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Tete (InCOVID 2020) - Resultados Preliminares -
Seroprevalence of SARS-CoV-2 Infection Among Occupational Groups from Bucaramanga Metropolitan Area, Colombia. Preprint
GHDx Entry last modified on: Oct 5, 2022
Sero-pravelence of SARS CoV-2 IgM and IgG Antibodies Amongst Blood Donors in Nigeria. Preprint
Scientific literature:
Epi surveillance
Serum-epidemiological Survey of SARS-CoV-2, City of Maputo (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Maputo (InCOVID 2020) - Resultados Preliminares -
Serum-epidemiological Survey of SARS-CoV-2, City of Quelimane (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Quelimane (InCOVID 2020) - Resultados Preliminares -
Prevalence and Time Trend of SARS-CoV-2 Infection in Puducherry, India, August-October 2020
GHDx Entry last modified on: Jun 17, 2021
Canada COVID-19 Seroprevalence in Ontario: August 1 to August 31, 2020
COVID-19 Seroprevalence in Ontario: August 1 to August 31, 2020
Premise Child Health COVID-19 Health Services Disruption Survey 2020
Survey:
Cross-sectional - Individual
SARS-CoV-2 seroprevalence in Germany - a population based sequential study in five regions. Preprint
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of anti-SARS-CoV-2 IgG at the epidemic peak in French Guiana. Preprint
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of anti-SARS-CoV-2 antibodies in Iquitos, Loreto, Peru. Preprint
GHDx Entry last modified on: Jun 18, 2021
United States - Ohio Prevalence of Current and Past COVID-19 in Adults July 2020
Prevalence of Current and Past COVID-19 in Ohio Adults
Survey:
Epi surveillance - Individual
Bhutan Royal Centre for Disease Control Quarterly Disease Surveillance Bulletin: Third Quarter, July-September 2020
RCDC Surveillance Bullletin, 28-39 Weeks, Volume 23, 3rd Quarter 2020 (1st July to 30 September) 2020
Epi surveillance:
Subnationally representative
Serum-epidemiological Survey of SARS-CoV-2, City of Pemba (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Pemba (InCOVID 2020) - Resultados Preliminares -
Prevalence of SARS-CoV-2 in six districts in Zambia in July, 2020: a cross-sectional cluster sample survey
GHDx Entry last modified on: Feb 10, 2022
Israel - Press Releases Results of the National Serological Survey for Novel Coronavirus
GHDx Entry last modified on: May 12, 2022
Canada COVID-19 Seroprevalence in Ontario: July 4 to July 31, 2020
GHDx Entry last modified on: May 12, 2022
Rapid increase of SARS-CoV-2 seroprevalence during the 2020 pandemic year in the population of the city of Tirana, Albania. Preprint
GHDx Entry last modified on: May 12, 2022
Sero-prevalence of SARS-CoV-2 Antibody Among Adults in the General Population in Diredawa, Ethiopia. Preprint
GHDx Entry last modified on: Sep 13, 2022
Dramatic Rise of Seroprevalence Rates of SARS-CoV-2 Antibodies among Healthy Blood Donors: The evolution of a Pandemic. Preprint
GHDx Entry last modified on: Oct 6, 2022
Presence of antibodies against SARS-CoV-2 in the district area Rinkeby-Kista, Stockholm, 22–24 June 2020
Förekomsten av antikroppar mot SARS-CoV-2 i stadsdelsområdet Rinkeby-Kista, Stockholm, 22–24 juni 2020
Survey:
Community - Cross-sectional - Exam - Urban only
Health Minister Fahrettin Koca announced the results of Turkey's antibody test
Sağlık Bakanı Fahrettin Koca Türkiye’nin antikor testi sonuçlarını açıkladı
Suriname COVID-19 Situation Report 2020
GHDx Entry last modified on: May 12, 2022
Subscribe